Mettler-Toledo International, Inc. $MTD Shares Acquired by National Pension Service

National Pension Service increased its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 0.6% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 37,470 shares of the medical instruments supplier’s stock after purchasing an additional 229 shares during the quarter. National Pension Service owned 0.18% of Mettler-Toledo International worth $44,017,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp raised its holdings in shares of Mettler-Toledo International by 71.3% during the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock worth $1,062,257,000 after purchasing an additional 376,419 shares during the period. Alliancebernstein L.P. grew its position in shares of Mettler-Toledo International by 21.6% during the 1st quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock valued at $837,653,000 after buying an additional 126,147 shares during the last quarter. PineStone Asset Management Inc. grew its position in shares of Mettler-Toledo International by 41.9% during the 2nd quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier’s stock valued at $392,766,000 after buying an additional 98,737 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Mettler-Toledo International by 42.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 305,722 shares of the medical instruments supplier’s stock worth $361,030,000 after acquiring an additional 90,395 shares during the period. Finally, Nuveen LLC bought a new position in Mettler-Toledo International in the first quarter worth about $71,897,000. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Stock Performance

Shares of MTD stock opened at $1,404.27 on Friday. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,471.06. The firm has a market capitalization of $28.69 billion, a PE ratio of 35.56, a price-to-earnings-growth ratio of 4.19 and a beta of 1.41. The stock has a fifty day moving average of $1,334.60 and a two-hundred day moving average of $1,248.36.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. The business had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $997.36 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company’s revenue was up 7.9% on a year-over-year basis. During the same period in the previous year, the business earned $10.21 earnings per share. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. Equities research analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

MTD has been the subject of several recent research reports. Stifel Nicolaus upped their target price on Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a report on Monday, November 10th. Barclays boosted their price objective on Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the company an “overweight” rating in a research report on Monday, November 10th. Bank of America upped their price objective on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a research note on Monday, September 22nd. Wells Fargo & Company raised their target price on Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the company an “equal weight” rating in a research note on Monday, November 10th. Finally, Citigroup boosted their price target on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a report on Monday, November 10th. Five analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Mettler-Toledo International has an average rating of “Hold” and an average target price of $1,406.50.

Insider Activity at Mettler-Toledo International

In other news, CEO Patrick Kaltenbach sold 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $1,462.50, for a total value of $2,925,000.00. Following the completion of the sale, the chief executive officer directly owned 3,670 shares of the company’s stock, valued at approximately $5,367,375. This represents a 35.27% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Elisha W. Finney sold 474 shares of the stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $1,433.57, for a total transaction of $679,512.18. Following the completion of the transaction, the director owned 311 shares of the company’s stock, valued at $445,840.27. This trade represents a 60.38% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 11,549 shares of company stock valued at $16,736,223 over the last quarter. Corporate insiders own 1.94% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.